ALL Relapsed/Refractory
Sort by:
Total Health
CAR T-Cell Therapy Innovations in ALL and CLL
FEATURING
Nitin Jain
- 2 views
- March 10, 2025
Nicholas Short
Clinical Use of MRD in Adult ALL: Recommendations From a Panel of U.S. Experts
- 10 views
- February 28, 2025
OncoPharm
Revumenib for KMT2A+ R/R Acute Leukemias - Drug Overview and Clinical Pearls
FEATURING
John Bossaer
- 18 views
- February 14, 2025
GRACE
HSCT & Cell Therapy 101: Overview of Types, Processes, Supportive Care, and Toxicities
FEATURING
Muhammad Salman Faisal
- 21 views
- February 6, 2025
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Highlights in Ph+ ALL
FEATURING
Fadi Haddad
- 112 views
- January 21, 2025
- 1
Louisville Hematology Highlights
2024 Review of Frontline Treatment in ALL
FEATURING
Nicholas Short
- 63 views
- January 21, 2025
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Dose Optimization of Inotuzumab Ozogamicin in Adult Patients With R/R ALL
FEATURING
Daniel J. DeAngelo
- 32 views
- January 15, 2025
- 1
Northwestern Medicine Oncology and Hematology
Approach to MRD in T-Cell ALL
FEATURING
Shira Dinner
- 19 views
- December 30, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Highlights in Adult ALL and Implications for Practice
FEATURING
Ryan Cassaday
- 330 views
- December 23, 2024
- 6
University of Illinois Cancer Center
Emerging Induction and Consolidation Regimens in ALL
FEATURING
John Quigley
- 7 views
- December 20, 2024
Oncology 2024 Year in Review
Year in Review 2024 - Transformative FDA Approvals in Precision Oncology Across Various Cancer Types
FEATURING
Vivek Subbiah
- 2,837 views
- December 17, 2024
- 8
Winship Cancer Institute - Emory University
FDA Approved First Oral Solution of Imatinib
FEATURING
Aseala Abousaud
- 54 views
- December 13, 2024
- 1
Muhammad Abid
Infectious Complications in Pts Receiving CD19 vs. BCMA Targeted CAR-T Therapy
- 19 views
- December 10, 2024
- 1
ecancer
Transplantation in Adult ALL: Current Guidelines and Key Considerations
FEATURING
Sameer Tulpule
- 42 views
- October 30, 2024
Yale Cancer Center
B-ALL Case Discussion: Management of Relapsed Ph- Disease
- 32 views
- October 29, 2024
Marina Konopleva
Considering Venetoclax in AML and ALL - Which Patients and Why
- 69 views
- October 23, 2024
- 2
Marlise R. Luskin
Treating Adult B-ALL: CAR-T vs. Bispecifics vs. Monoclonals
- 107 views
- October 21, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Pediatric ALL: Etiology, Diagnosis and Management
FEATURING
ÖZlem TüFekçI GüRocak
- 26 views
- October 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
ALL Case: B-ALL Arising During Len Maintenance in Myeloma Patient
FEATURING
Kubra Ozsoy
- 5 views
- October 15, 2024
Cleveland Clinic Taussig Cancer Institute
R/R B-ALL Case Discussion: Managing Toxicities of Immunotherapies
FEATURING
Bassam Estfan,
Paolo Caimi
- 29 views
- October 3, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Ph+ ALL Management: Case-Based Discussion
FEATURING
Kivanc Koruk
- 23 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Immunotherapy and Sequencing CD19-Targeted Therapies in Adults With R/R ALL
FEATURING
Elias Jabbour
- 44 views
- September 27, 2024
- 1